O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)

O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 60; no. 1; p. S524
Main Authors: Lawitz, E, Ghalib, R, Rodriguez-Torres, M, Younossi, Z.M, Corregidor, A, Sulkowski, M.S, DeJesus, E, Pearlman, B, Rabinovitz, M, Gitlin, N, Lim, J.K, Pockros, P.J, Fevery, B, Lambrecht, T, Ouwerkerk-Mahadevan, S, Callewaert, K, Symonds, W.T, Picchio, G, Lindsay, K, Beumont-Mauviel, M, Jacobson, I.M
Format: Journal Article
Language:English
Published: Elsevier B.V 01-04-2014
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(14)61460-4